The FDA has accepted Belite Bio’s application for tinlarebant and [...]

CellProthera and Alfresa Holdings have signed an MOU covering potential [...]

The FDA has approved Moderna’s mRNA seasonal influenza vaccine mFLUSIVA [...]

Vaderis Therapeutics has raised $152M and started a global Phase [...]

The EMA’s CHMP has recommended EU approval of Lynavoy for [...]

The EMA’s CHMP has recommended approval of NEZGLYAL for boys [...]

Atsena Therapeutics has received EMA orphan designation for two gene [...]

Tenpoint Therapeutics has submitted a Marketing Authorization Application (MAA) to [...]

Hansa Biopharma’s Biologics License Application (BLA) for imlifidase has been [...]

CellProthera has acquired full rights to the transendocardial catheter originally [...]